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SUMMARY
Subacute sclerosingpanencephalitis (SSPE) is a rare degenerative disease ofthe
central nervous system that affectsprimarily children and adolescents. It is a late
manifestation of measles virus infection. In a 20-year period (1965-85) there
have been 26 cases ofSSPE in Northern Ireland, a frequency ofapproximately
one case per 1.2 million population per year. Males were affected more
frequently than females. In otherparts ofthe world the incidence ofthis disease
has been dramatically reduced following effective measles immunisation
programmes. The vaccination rate in Northern Irelandprobably remains too low
to have a similar effect.
INTRODUCTION
Subacute sclerosing panencephalitis (SSPE) was first recognised as a sporadic
encephalitis with a subacute course in the early part ofthe 20th century. In 1933
Dawson described intranuclear inclusions and postulated a viral aetiology.1 The
term 'subacute sclerosing panencephalitis' was first used by Van Bogaert
following careful studies of the white matter lesions.2 In 1967 the role of the
measles virus was postulated by Connolly, Allen, Hurwitz and Millar when they
demonstrated measles antigen in brain cellsand high titresofmeaslesantibody in
serum and CSF.3 The first cases in Northern Ireland, also reported by Connolly,
Allen, Hurwitz and Millar, were three patients who all became ill within a six-
month period in 1965.4
SSPE is now recognised as a worldwide disease with an incidence in most studies
of about one per million population per year.5 However, even in North America
where most epidemiological studies have been carried out, there has been some
variation in incidence from state to state. This paper presents a retrospective
study of all cases of SSPE known to the Regional Neurological Unit and the
Regional Virus Laboratory at the Royal Victoria Hospital where all such cases
would be expected to be referred.
CLINICAL FEATURES
During the period 1965-85 there were 26 documented cases of SSPE in
Northern Ireland giving an overall incidence of 1.2 cases per million population
per year. The disease had a definite predilection for males, boys being affected
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eight times more frequently than girls (23 males, three females). This male
predominance has been a consistent finding in all reported series.
It has been stated that measles infection at an early age is a risk factor for the
development of SSPE.6 In this series, the age of measles infection was known in
19 cases. Three patients had measles underthe age oftwo years, 13 between the
ages of two and four years and only three over the age offour years, the average
age of measles infection being 2.9 years. None of the cases had a history of
measles vaccination. The age of onset ofthe encephalitis varied from three to 19
years with a mean of 10.8 years and there was a mean latent period between
measles infection and the development of SSPE of 8.0 years, range two to 15
years. (Fig 1).
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Fig 1. The age of onset ofthe encephalitis, and the age of measles infection in 26 patients with SSPE
from 1965 to 1985.
The clinical course of the disease can be divided into four characteristic stages
but there is no sharp demarcation between the stages, and the speed at which
one merges into the next is variable. These stages are summarised in Table 1. In
thisseries, thefirst stage was mostfrequently characterised by intellectual impair-
ment and changes in behaviour. The onset was often very gradual so that it was
difficult to bespecific about the exact time ofonset ofthe illness. In several cases,
signs were first detected by school teachers who noticed impaired intellectual
performance. Deterioration in writing and school work was thought to be due, in
six children, to difficulty in performing fine movements with the hands, and, in
five others to some visual disturbance. Impaired powers of concentration and
decreased intellectual abilityfollowed in most cases, while 12 patients were noted
to undergo personality change, most often becoming emotionally withdrawn.
Frequent falls were another common early symptom, and a history oftrauma was
obtained in 25% of cases. Although this was probably an effect of the disease,
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the trauma was frequently cited by patient's relatives as the cause of the child's
symptoms. In all cases the trauma was minor and on admission 21 of the 26
patients were noted to have unsteadiness of gait.
TABLE I
Clinical features ofSSPE, in 26 patients, during the progress ofthe disease
STAGE 1: MENTAL DISTURBANCES
Intellectual deterioration 24
Personality or behaviourchanges 12
Slurred speech 1 1
Poor concentration 9
Dressing dyspraxia 5
STAGE 2: MOTOR DISTURBANCES
Frequent falls/Unsteadiness ofgait 21
Myoclonicjerks 21
Generalised/focal seizures 10
Cortical blindness 8
Difficulty performing fine movements with hands 6
Othervisual loss 5
Urinary incontinence 7
Choreform movements 2
Facial weakness 1
STAGES 3 AND 4: HYPERTONIA AND DECEREBRATION
Absent speech 22
Extrapyramidal rigidity 13
Decerebrate rigidity 12
Difficulty in swallowing 11
Laryngeal spasms 3
The second stage was characterised by motor disturbances: myoclonic jerking
occurred in 21 patients and generalised seizures in 10. At this stage the virus is
thought to have spread to the white matter and focal deficits such as cortical
blindness were sometimes apparent. This second stage lasted for a variable
length of time, but in all cases the disease followed a progressive downhill course,
and during the later stages there was further loss of higher cortical function with
increasing lower limb spasticity. This progressed to severe extrapyramidal rigidity
and finally complete loss of cerebral cortex function and akinetic mutism.
Twenty of the patients have died, usually from terminal lung infections. Six are
still alive, at least three of whom appear to have gone into a state of remission,
a previously recognised feature of the condition,7 sometimes resulting in survival
for many years despite severe disablement.
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INVESTIGATIONS
EEG
All 26 cases had an electroencephalogram. The typical tracing of SSPE is a slow
background activity of 4 - 8 c/s with periodic outbursts of high amplitude slow
waves at approximately 3 c/s occurring at intervals of 10 - 15 seconds, which
may be accompanied by generalised myoclonicjerking.8 This type oftracing was
seen in 25 of the 26 cases, but the timing of the investigation is important as in
many cases the initial EEG was non-specific showing a generalised abnormality
or even, as in three cases, a focal abnormality. (Table II).
TABLE II
Investigations
Patient Sex
1 M
2 M
3 M
4 F
5 M
6 M
7 M
8 M
9 F
10 M
11 M
12 M
13 M
14 M
15 M
16 M
17 M
18 M
19 M
20 M
21 M
22 M
23 M
24 M
25 F
26 M
Typical
EEG
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Measles Typical
Cerebrospinal fluid Ab Titre histological
Protein WCC Lange Serum CSF findings
N
N
N
N
.80
N
N
N
N
N
N
N
N
N
N
N
N
N
1.14
N
(1) 0.94
(2) 0.68
N
N
N
N
N
N
N
7
6
N
N
N
N
N
7
N
N
N
N
N
N
N
N
N
20
5
8
N
N
N
p
N
N
p
N
p
N
N
p
p
N
p
N
N
N
p
N
p
p
p
2048 128
1024 128
128 32
2560 256
320 40
640 80
640 16
2560
640 32
2560 64
5120 128
5120 32
2560 64
5120 64
2560 64
640 32
320 32
> 10240 64
>10240 256
> 10240 512
2560 16
160 16
2560 128
320 64
2560 64
1280 64
Protein N = < .45 g/1
WCC N = < 4 cells/pl
Lange P = Paretic
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Yes
Yes
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Yes
Yes
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CSF
Every patient had CSF analysis carried out. In 19 the protein and cell count was
within normal limits. A raised protein value was recorded in four cases, in five
cases there was a modest lymphocytosis of 6 - 8 cells/pl, and a further case had
20 lymphocytes/pi on the first of two occasions when lumbar puncture was
carried out. A paretic Lange curve was another relatively common finding (in 11
out of 21 cases measured).
An elevated CSF measles antibody titre at greater than 1:8 was found in 25 of
the patients (in the other case the CSF antibody titre was not measured). It has
been shown in these cases that measles virus antibody in the CSF is specifically
raised when compared with polio type 2 antibody, indicating either a selective
permeability of measles virus antibody through the blood brain barrier or measles
virus antibody production within the CNS.9
HISTOLOGY
Six of the patients had a brain biopsy performed and nine had a post-mortem
examination. Three of the biopsies showed features of encephalitis with
congestion of the brain. In the later stages there was nerve cell degeneration with
loss of nerve fibres and glial replacement. Two cases were more specific in
demonstrating inclusion bodies or measles antigen using immunofluorescence.
Thefinal casedemonstrated onlyslight congestion ofthe cortex but wasotherwise
normal.
Post-mortem examination was performed in nine cases. While the brains
appeared macroscopically normal, on microscopy extensive perivascular infiltrat-
ion in both grey and white matter was found, together with degeneration and loss
of neurones. In all but one case, intranuclear inclusion bodies and/or measles
antigen were demonstrated. The neuronal loss was accompanied by gliosis, but
with little destruction of myelin, both of which features are characteristic of this
condition. (Fig 2).
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Fig 2.
Neurone with
intranuclear
inclusion body
in SSPE, x 400.
(Courtesy of
Professor
I V Allen).
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TREATMENT
A small group of patients survived for several years and spontaneous remissions
have been reported.7 Over the last 20 years, several agents have been advocated
to treat SSPE: steroids were used in two cases with little or no affect. Anti-viral
therapy with amantadine (two cases), vidarabine (one case) and interferon (three
cases, administered in the Hospital for Sick Children, Great Ormond Street,
London), did not prove helpful in our cases although there have been reports of
their efficacy from other centres.10
Following an observation in-vitro that the measles virus is susceptible to heat,'1
hyperpyrexial therapy was administered to five patients. This was performed by
raising the body temperature to 40.5C for 18 hours on two occasions one week
apart and then for 24 hours two weeks later. There was no apparent benefit. It
has been suggested that patients with SSPE have a deficiencyofcellular immunity
and that this might be restored by small amounts of transfer factor;12 also that
plasmaphoresis might reduce the high titres of measles antibody. One of our
cases therefore underwent a combination of these proposed therapies, but there
was no beneficial effect.
Two of our patients received isoprinosine, a drug which is thought to have an
immunomodulating effect, and which current research suggests may be more
effective than any other form of therapy in reducing the mortality and morbidity
of SSPE.10 It did not alter the outcome. Palliative measures continue to have an
important part to play in management, particularly the use of anticonvulsants,
nutritional supplements, physical aids and good nursing care.
CONCLUSION
SSPE remains a distressing condition. It runs a progressive course with a high
mortality rate and those that survive do so with profound neurological deficits.
Although the measles virus has long been held to be responsible for the disease,
only recently has it been more fully understood how the virus produces its effect
so late after the acute infection. It is suggested that the virus enters the host at a
vulnerable immunological period, then appears to escape the natural host
reaction and enters the central nervous system. The CNS being a relatively
protected site immunologically, the virus survives. For some still poorly under-
stood reason the virus is defective and cannot mature into complete virions in the
brain. This failure to produce virion progeny by the persistently infected cells
distinguishes SSPE from acute measles virus infection and, as a result, virus
antigen is not exposed to the extra-cellular space where it may be recognised and
destroyed by the host immune response. Only when the cell dies and the virus is
extruded does an antibody response occur.
There is so far no effective therapy. In the United States of America a decline in
measles infection occurred between 1964 and 1968, and this was reflected by a
similar fall in SSPE from 1971 onwards.5 These changes appeared to correlate
with the measles immunisation programme which began in 1964. Although a
small number of cases of SSPE have been reported in previously immunised
individuals, it has not been shown that the vaccine was responsible and the
risk of developing SSPE after measles infection is 10 times greater than after
vaccination.'3 To date, there does not appear to have been a similar reduction in
the incidence ofthe disease in Northern Ireland and this isprobably a reflection of
ourlow vaccination rate whichiscurrently around 15% . The best hope for control
of the disease locally lies in achieving high levels of vaccination against measles.
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We are grateful to the following colleagues forallowing us to report on cases undertheircare: DrJ H D
Millar, Dr J A Lyttle, Dr S A Hawkins, Dr V H Patterson. Also to Dr J H Connolly ofthe Regional Virus
Laboratory for his help and advice, and Professor Ingrid Allen for the histological data. Some of the
autopsy examinations were carried out in the middle ofthe night in order to obtain fresh material. The
five children treated byhyperpyrexia were under the careofthe Intensive Care Unit atthe Royal Belfast
Hospital for Sick Children.
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